Key result
Regular 12-lead ECG and routine cardiac enzyme measurement were more sensitive for diagnosing myocardial infarction in the ICU compared to 2-lead monitoring and symptom-provoked testing.
Why the study?
What is the evidence concerning the diagnosis and treatment of myocardial infarction in the intensive care unit?
Systematic Review
What is the evidence concerning the diagnosis and treatment of myocardial infarction in the intensive care unit?
In ICU patients, regular 12-lead ECG and routine cardiac enzyme measurements improve MI detection, while angiography is low-yield without echocardiographic wall motion abnormalities.
INTRODUCTION: Patients in the intensive care unit are vulnerable to myocardial injury from a variety of causes, both ischaemic and non-ischaemic. It is challenging for ICU clinicians to apply the conventional guidance concerning diagnosis and treatment. We conducted this review to examine the evidence concerning diagnosis and treatment of myocardial infarction in the ICU. METHODS: A systematic review was performed to identify relevant studies. RESULTS: 19 studies concerning use of ECG, cardiac enzymes, echocardiography and angiography were identified. 4 studies considered treatment of myocardial infarction. CONCLUSIONS: Regular 12 lead ECG or 12 lead ECG monitoring is more sensitive than 2 lead monitoring, regular measurement of cardiac enzymes is more sensitive than when provoked by symptoms. Coronary angiography rarely identifies treatable lesions, without regional wall motion abnormality on echocardiography. Evidence relating to treatment was limited. A potential strategy to diagnose myocardial infarctions in the ICU is proposed.
No takes yet. Share an insight, caveat, or question.
Carroll et al. (2016) conducted a systematic review in Myocardial infarction in the intensive care unit. Diagnostic and treatment strategies (ECG, cardiac enzymes, echocardiography, angiography) was evaluated. Regular 12-lead ECG and routine cardiac enzyme measurement were more sensitive for diagnosing myocardial infarction in the ICU compared to 2-lead monitoring and symptom-provoked testing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: